Regeneron Pharmaceuticals

REGN · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.202%

12M weight contribution

-0.004 pp

3M weight contribution

-0.010 pp

12M price return

+23.4%

Share of matched S&P 500 members

Monthly observations through Nov 2021

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Nov 2021	$59.8bn	0.202%	-0.004 pp	+23.4%	Yes
Oct 2021	$60.1bn	0.201%	-0.041 pp	+17.7%	Yes
Sep 2021	$56.9bn	0.200%	+0.199 pp	+8.1%	Yes
Aug 2021	$63.3bn	0.212%	+0.211 pp	+8.6%	Yes
Jul 2021	$54.0bn	0.185%	+0.185 pp	-9.1%	Yes
Jun 2021	$52.5bn	0.185%	+0.185 pp	-10.4%	Yes
May 2021	$47.2bn	0.169%	+0.169 pp	-18.0%	Yes
Apr 2021	$45.2bn	0.164%	-0.113 pp	-8.5%	Yes
Mar 2021	$44.5bn	0.087%	+0.087 pp	-3.1%	No
Feb 2021	$42.3bn	0.085%	+0.084 pp	+1.3%	No
Jan 2021	$47.3bn	0.113%	-0.043 pp	+49.1%	No
Dec 2020	$45.4bn	0.184%	+0.011 pp	+28.7%	Yes
Nov 2020	$48.5bn	0.206%	+0.031 pp	+39.8%	Yes
Oct 2020	$51.1bn	0.242%	+0.092 pp	+77.5%	Yes
Sep 2020	$52.6bn	0.000%	-0.138 pp	+101.8%	No
Aug 2020	$58.2bn	0.000%	-0.148 pp	+113.7%	No
Jul 2020	$59.4bn	0.000%	-0.152 pp	+107.4%	No
Jun 2020	$58.6bn	0.000%	-0.158 pp	+99.2%	No
May 2020	$57.6bn	0.000%	-0.165 pp	+103.1%	No
Apr 2020	$49.4bn	0.277%	+0.097 pp	+53.3%	Yes
Mar 2020	$45.9bn	0.000%	-0.221 pp	+18.9%	No
Feb 2020	$41.8bn	0.000%	-0.234 pp	+3.2%	No
Jan 2020	$31.8bn	0.157%	+0.024 pp	-21.3%	No
Dec 2019	$35.3bn	0.173%	+0.048 pp	+0.5%	Yes

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.